Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Joe Turgeon
Recent Posts
BLUE WATER PETROLEUM LAUNCHES ITS THERMO VARNISH PRODUCT
Metatron Releases Chat-GPT4 Powered AI Content Mobile Apps
ChatGPT4-powered AI Content Mobile Applications
Better Carbon Offsets With AI: How Arma’s Innovative Artificial Intelligence Technology Can Create Offsets With More Accuracy and Value
Winners Creates Another New Expected Revenue Stream – Signs Terms Sheet With “Horse Races Now” and “Next Play Digital”
Popular Post
-
InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of FDA-Registered OTC Rechargeable Hearing Aids on Target.com
-
Sports Gambling and the Horse Racing Market
-
ZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEY
-
Principal Solar to Acquire Minerva-Rockdale Leases, Wells, and Assets
-
Kona Gold Beverage, Inc Announces its Ooh La Lemin Lemonades to be sold in Town Pump Convenience Stores in Montana
